Skip Navigation


NDT Advance Access originally published online on October 12, 2007
Nephrology Dialysis Transplantation 2008 23(3):860-870; doi:10.1093/ndt/gfm670
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/3/860    most recent
gfm670v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Li, M.
Right arrow Articles by Batuman, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, M.
Right arrow Articles by Batuman, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells

Min Li, Kathleen S. Hering-Smith, Eric E. Simon and Vecihi Batuman

Section of Nephrology and Hypertension, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA

Vecihi Batuman, MD, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-45, New Orleans, Louisiana 70112, USA. E-mail: vbatuma{at}tulane.edu



  Abstract

Background. To determine the role of epithelial–mesenchymal transition (EMT) as a potential mechanism contributing to the characteristic tubulointerstitial renal fibrosis in multiple myeloma, we examined whether myeloma light chains (LCs) directly induce EMT in human renal proximal tubule epithelial cells (PTECs).

Methods. As positive controls we used TGF-β1 and cyclosporine A (CsA), two agents known to induce EMT in PTECs. Human LCs were isolated and purified from the urine of myeloma patients with modest renal insufficiency without evidence of glomerular involvement. HK-2 cells were exposed to kappa LC (25 µM) for periods up to 72 h.

Results. LCs induced marked cellular morphological alterations in PTECs, accompanied with increased expression levels of profibrotic TGF-β1, FSP-1 and extracellular matrix components. Using semiquantitative immunoblotting and RT-PCR, we observed that the expression of E-cadherin decreased after 24 h, while the expression of {alpha}-SMA increased in PTEC after continuous exposure to {kappa}-LCs. Human serum albumin (HSA; 160 µM) had less potent effect on the expression of EMT-related molecules. Neutralizing TGF-β1 antibody blocked CsA-induced EMT but had no effect on LC-exposed cells. LC-induced EMT and the secretions of IL-6 and MCP-1 were, however, markedly attenuated by p38 MAPK interference. The use of bone morphogenetic protein-7 or pituitary adenylate cyclase-activating polypeptide (PACAP) induced the formation of cell aggregates, and the reacquisition of E-cadherin expression and renal proximal tubule epithelial morphology within the confluent cell monolayer during and after LC exposure.

Conclusions. These findings demonstrate that LC is a direct stimulus for EMT in PTECs. LC-induced EMT involved multiple cytokines, is modulated by p38 MAPK, but appeared independent of the action of TGF-β1. LC-induced EMT may be an important mechanism of kidney injury associated with myeloma and may be reversible upon the administration of exogenous PACAP.

Keywords: cytokines; MAPK; myeloma kidney; PACAP; renal fibrosis; TGF-β1

Received for publication: 4. 1.07
Accepted in revised form: 3. 9.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Z. Tang, B. Lu, E. Hatch, S. H. Sacks, and N. S. Sheerin
C3a Mediates Epithelial-to-Mesenchymal Transition in Proteinuric Nephropathy
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Khawam, J. Giron-Michel, Y. Gu, A. Perier, M. Giuliani, A. Caignard, A. Devocelle, S. Ferrini, M. Fabbi, B. Charpentier, et al.
Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor {alpha} Chain, Epithelial-to-Mesenchymal Transition
Cancer Res., February 15, 2009; 69(4): 1561 - 1569.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. A. Hutchison, S. Harding, P. Hewins, G. P. Mead, J. Townsend, A. R. Bradwell, and P. Cockwell
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1684 - 1690.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.